Microparticles of rifampicin: comparison of pulmonary route with oral route for drug uptake by alveolar macrophages, phagocytosis activity and toxicity study in albino rats

Simulated Biological Fluids with Possible Application in Dissolution Testing

(2015) Margareth R. C. Marques et al.   DISSOLUTION TECHNOLOGIES

Tuberculosis: from molecular pathogenesis to effective drug carrier design

(2012) Devyani Dube et al.   DRUG DISCOVERY TODAY

A novel dry powder inhalable formulation incorporating three first-line anti-tubercular antibiotics

(2012) John Gar Yan Chan et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Preparation of rifampicin/lactose microparticle composites by a supercritical antisolvent-drug excipient mixing technique for inhalation delivery

(2012) Courtney A. Ober et al.   POWDER TECHNOLOGY

Innate Immune Recognition ofMycobacterium tuberculosis

(2011) Johanneke Kleinnijenhuis et al.   Clinical & Developmental Immunology

A new respirable form of rifampicin

(2011) Yoen-Ju Son et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Isoniazid Proliposome Powders for Inhalation—Preparation, Characterization and Cell Culture Studies

(2011) Wipaporn Rojanarat et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

One-step preparation of chitosan solid nanoparticles by electrospray deposition

(2010) Shaoling Zhang et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Pulmonary delivery of cisplatin–hyaluronan conjugates via endotracheal instillation for the treatment of lung cancer

(2010) Yumei Xie et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Inhalable nanoparticles, a non-invasive approach to treat lung cancer in a mouse model

(2010) Wilson H. Roa et al.   JOURNAL OF CONTROLLED RELEASE

Inhaled drug therapy for treatment of tuberculosis

(2010) Amit Misra et al.   TUBERCULOSIS

Effects of nanomaterial physicochemical properties on in vivo toxicity

(2009) Kristin L. Aillon et al.   ADVANCED DRUG DELIVERY REVIEWS

New old challenges in tuberculosis: Potentially effective nanotechnologies in drug delivery

(2009) Alejandro Sosnik et al.   ADVANCED DRUG DELIVERY REVIEWS

Formulation and Pharmacokinetics of Self-Assembled Rifampicin Nanoparticle Systems for Pulmonary Delivery

(2009) Jean C. Sung et al.   PHARMACEUTICAL RESEARCH

Slow Release Formulations of Inhaled Rifampin

(2008) Intira Coowanitwong et al.   AAPS Journal

Intracellular Time Course, Pharmacokinetics, and Biodistribution of Isoniazid and Rifabutin following Pulmonary Delivery of Inhalable Microparticles to Mice

(2008) R. K. Verma et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A hand-held apparatus for “nose-only” exposure of mice to inhalable microparticles as a dry powder inhalation targeting lung and airway macrophages

(2008) Jatinder Kaur et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis

(2008) Katsuya Ohashi et al.   JOURNAL OF CONTROLLED RELEASE

Antimetastatic activities of pegylated liposomal doxorubicin in a murine metastatic lung cancer model

(2008) Yongming Zhang et al.   JOURNAL OF DRUG TARGETING

Nanoparticle formulations in pulmonary drug delivery

(2008) Mark M. Bailey et al.   MEDICINAL RESEARCH REVIEWS

Stimulation of Phagocytic Activity of Alveolar Macrophages Toward Artificial Microspheres by Infection with Mycobacteria

(2008) Keiji Hirota et al.   PHARMACEUTICAL RESEARCH